Identifying New IBD Drug Targets & Accompanying Patient Stratification Biomarkers From Large Multi-Modal Datasets

Time: 5:00 pm
day: Day One


  • Discussing the importance and power of large multi-model datasets to identify new therapeutic targets in IBD
  • Reviewing Anti-TL1A and anti-CD30L precision medicine case studies to highlight the need for patient stratification
  • Identifying genomic variants as patient stratification biomarkers